Biotage AB joins forces with MultiSynTech GmbH and enters the peptide synthesis business
Biotage announced that the company will enter the peptide synthesis business, through two new agreements with German company MultiSynTech GmbH. The agreements concern both the distribution rights for MultiSynTech's systems and the establishment of a joint development project.
The agreements with MultiSynTech will grant Biotage distribution rights for all current MultiSynTech peptide synthesis systems. Biotage and MultiSynTech have also agreed on a joint development project to design and market a new microwave-aided peptide synthesis system, which will increase yield and speed in peptide synthesis.
"We look forward to working in close collaboration with Biotage. Biotage has a proven sales and support team that dramatically expands our coverage outside Central Europe, and really opens opportunities for our current products in USA, UK, Nordic and Asian regions." says Udo Treffer, CEO of MultiSynTech.
"MultiSynTech is the clear leader in robotic peptide synthesis. This joint development project will combine the proven performance of the current MultiSynTech robotic synthesizer with Biotage microwave technology in a unique integrated system." says Torben Jørgensen, CEO of Biotage.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Bone degradation process within metastatic breast cancer identified
Shimadzu acquires specialist for isotope labeled standards
CLC bio tests Next Generation Sequencing solution on African tuberculosis data
TTP LabTech Announce US Expansion to Meet Growing Customer Demand
Oncodesign announces EUR 10 million funding for oncology biomarker program IMAkinib
Let there be tissue-penetrating light - Scientists develop new nanoscale method to fight cancer
NUS partners FIND to discover novel biomarkers for Tuberculosis detection
New technology makes clinical research more precise
First-hand expertise at the biggest ever analytica Vietnam
Taking malaria breath markers to the world
New chemical imaging technique could help in the fight against atherosclerosis, suggests research